Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Everett

Showing results (301-310 of 361) with videos related to

Pageof 37
Sort By:
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|November 24, 2019
The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic ReviewJackson L Williams, Julian M Everett, Nathan M D'Cunha, et al.
Medical Care|January 8, 2026
Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD StudyLyndsay A Nelson, Erin M Bergner, Amos Adler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pyloriS M Everett, R Singh, C Leuratti, et al.
Research in Social & Administrative Pharmacy : RSAP|October 8, 2014
Medication oversupply in patients with diabetesCarolyn T Thorpe, Heather Johnson, Anna Legreid Dopp, et al.
Cardiovascular Diabetology|February 8, 2024
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Diabetologia|March 21, 2024
Effectiveness and safety of empagliflozin: final results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Cardiovascular Diabetology|March 19, 2024
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Frontline Gastroenterology|March 15, 2024
Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitisWafaa Ahmed, Deepak Joshi, Matthew T Huggett, et al.
JAAPA : Official Journal of the American Academy of Physician Assistants|January 5, 2022
Teaming up in primary care: Membership boundaries, interdependence, and coordinationChristine M Everett, Sharron L Docherty, Elaine Matheson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk ModelDaniel H Solomon, Leah Santacroce, Jon T Giles, et al.
Pageof 37

Showing results (301-310 of 361) with videos related to

Sort By:
Pageof 37
Plant Foods for Human Nutrition (Dordrecht, Netherlands)|November 24, 2019
The Effects of Green Tea Amino Acid L-Theanine Consumption on the Ability to Manage Stress and Anxiety Levels: a Systematic ReviewJackson L Williams, Julian M Everett, Nathan M D'Cunha, et al.
Medical Care|January 8, 2026
Development and Value of a Centralized Text Message-based Tracking and Support Program for the PRECIDENTD StudyLyndsay A Nelson, Erin M Bergner, Amos Adler, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 25, 2001
Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pyloriS M Everett, R Singh, C Leuratti, et al.
Research in Social & Administrative Pharmacy : RSAP|October 8, 2014
Medication oversupply in patients with diabetesCarolyn T Thorpe, Heather Johnson, Anna Legreid Dopp, et al.
Cardiovascular Diabetology|February 8, 2024
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Diabetologia|March 21, 2024
Effectiveness and safety of empagliflozin: final results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Cardiovascular Diabetology|March 19, 2024
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE studyPhyo T Htoo, Helen Tesfaye, Sebastian Schneeweiss, et al.
Frontline Gastroenterology|March 15, 2024
Update on the optimisation of endoscopic retrograde cholangiography (ERC) in patients with primary sclerosing cholangitisWafaa Ahmed, Deepak Joshi, Matthew T Huggett, et al.
JAAPA : Official Journal of the American Academy of Physician Assistants|January 5, 2022
Teaming up in primary care: Membership boundaries, interdependence, and coordinationChristine M Everett, Sharron L Docherty, Elaine Matheson, et al.
Medrxiv : the Preprint Server for Health Sciences|February 27, 2026
Biomarkers for Atherosclerotic Cardiovascular Events in Rheumatoid Arthritis: Towards Validation of a Biomarker-Enhanced Risk ModelDaniel H Solomon, Leah Santacroce, Jon T Giles, et al.
Pageof 37